RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Peter R. Hoffmann to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Peter R. Hoffmann has written about Antibodies, Monoclonal.
Peter R. Hoffmann
Connection Strength
0.183
Antibodies, Monoclonal
  1. H?lper P, Schulz-Schaeffer W, Dullin C, Hoffmann P, Harper J, Kurtzberg L, Lonning S, Kugler W, Lakomek M, Erdlenbruch B. Tumor localization of an anti-TGF-? antibody and its effects on gliomas. Int J Oncol. 2011 Jan; 38(1):51-9.
    View in: PubMed
    Score: 0.084
  2. Bulut K, Pennartz C, Felderbauer P, Meier JJ, Banasch M, Bulut D, Schmitz F, Schmidt WE, Hoffmann P. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts. Eur J Pharmacol. 2008 Jan 14; 578(2-3):279-85.
    View in: PubMed
    Score: 0.067
  3. Ricciardelli C, Lokman NA, Pyragius CE, Ween MP, Macpherson AM, Ruszkiewicz A, Hoffmann P, Oehler MK. Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance. Oncotarget. 2017 Mar 14; 8(11):17819-17832.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support